E70.321

The ICD-10-CM code for tyrosinase positive oculocutaneous albinism is E70.321. The full clinical description is "Tyrosinase positive oculocutaneous albinism". E70.321 is a billable/specific code that can be used on insurance claims and medical billing.

ICD-10-CM code E70.321 represents “Tyrosinase positive oculocutaneous albinism”. It is classified under Chapter 4: Endocrine, Nutritional and Metabolic Diseases and is a billable/specific code that can be used on a claim.

Yes, E70.321 is a billable/specific ICD-10-CM code and can be used to indicate a diagnosis on a medical claim.

E70.321 is in Chapter 4: Endocrine, Nutritional and Metabolic Diseases (codes E00-E89).

E70.321 has Excludes1 notes indicating codes that cannot be used together with it, including: transitory endocrine and metabolic disorders specific to newborn (P70-P74); androgen insensitivity syndrome (E34.5-); congenital adrenal hyperplasia (E25.0); and 5 more.

E70.321 maps to 3 SNOMED CT concepts: 26336006, 11160000, 63450009. SNOMED CT is a clinical terminology used in electronic health records.

E70.321 is linked to 1 UMLS Concept Unique Identifier: C0268495. The UMLS (Unified Medical Language System) integrates multiple biomedical vocabularies maintained by the U.S. National Library of Medicine.

ICF (International Classification of Functioning, Disability and Health) codes describe how conditions like tyrosinase positive oculocutaneous albinism affect a person's functioning: body functions, activities, participation, and environmental factors. AutoICD provides ICF Core Sets for 12+ conditions and can map clinical text to ICF categories automatically. Browse the ICF directory to explore functioning codes.

There is no direct ICD-11 mapping available for E70.321 in the WHO crosswalk tables. This may mean the concept is classified differently in ICD-11. Use the ICD-10 to ICD-11 converter to search for related codes.